Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper

Thromb Haemost. 2024 Aug;124(8):770-777. doi: 10.1055/a-2261-1811. Epub 2024 Feb 5.

Abstract

Background: With the widespread use of direct oral anticoagulants (DOACs), there is an urgent need for a rapid assay to exclude clinically relevant plasma levels. Accurate and rapid determination of DOAC levels would guide medical decision-making to (1) determine the potential contribution of the DOAC to spontaneous or trauma-induced hemorrhage; (2) identify appropriate candidates for reversal, or (3) optimize the timing of urgent surgery or intervention.

Methods and results: The DOAC Dipstick test uses a disposable strip to identify factor Xa- or thrombin inhibitors in a urine sample. Based on the results of a systematic literature search followed by an analysis of a simple pooling of five retrieved clinical studies, the test strip has a high sensitivity and an acceptably high negative predictive value when compared with levels measured with liquid chromatography tandem mass spectrometry or calibrated chromogenic assays to reliably exclude plasma DOAC concentrations ≥30 ng/mL.

Conclusion: Based on these data, a simple algorithm is proposed to enhance medical decision-making in acute care indications useful primarily in hospitals not having readily available quantitative tests and 24/7. This algorithm not only determines DOAC exposure but also differentiates between factor Xa and thrombin inhibitors to better guide clinical management.

MeSH terms

  • Administration, Oral
  • Algorithms*
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Antithrombins
  • Clinical Decision-Making
  • Consensus*
  • Drug Monitoring / methods
  • Factor Xa Inhibitors* / blood
  • Factor Xa Inhibitors* / therapeutic use
  • Hemorrhage
  • Humans
  • Predictive Value of Tests
  • Reagent Strips
  • Reproducibility of Results
  • Tandem Mass Spectrometry

Substances

  • Factor Xa Inhibitors
  • Anticoagulants
  • Antithrombins
  • Reagent Strips